首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1288821

全球軟組織肉瘤診斷市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023年至2030年預測

Global Soft Tissue Sarcoma Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

軟組織肉瘤是一種影響身體結締組織的癌症，如肌肉、脂肪、血管和皮膚深層組織。這種肉瘤可以發生在身體的任何地方，由於其表現形式和位置的多樣性，不容易診斷。軟組織肉瘤的診斷通常從徹底的身體檢查和回顧病人的病史開始。醫療服務提供者還可能要求進行影像學檢查，如X射線、核磁共振或CT掃描，以觀察受影響的區域並確定腫瘤的大小和位置。儘早診斷和治療軟組織肉瘤是很重要的，因為如果不加以治療，它可以迅速生長和擴散。

市場動態：

新的和改進的診斷測試和技術的發展，如先進的成像技術和活檢方法，可以幫助在疾病的早期階段識別疾病，可能有助於市場的成長。此外，人們對早期發現和治療癌症的重要性的認識不斷提高，正在擴大定期檢查和篩查的規模；他們可能更傾向於尋求診斷測試，包括軟組織肉瘤的診斷測試，這可能會促進市場成長。

該研究報告涵蓋了波特的五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地瞭解行業結構，並在全球範圍內評估競爭吸引力。此外，這些工具還對全球軟組織肉瘤診斷市場的每個細分市場進行包容性評估。軟組織肉瘤診斷行業的增長和趨勢為這項研究提供了整體方法。

區域分析：

這一部分涵蓋了區域前景，強調了軟組織肉瘤診斷市場在北美、歐洲、亞太、拉丁美洲、中東和非洲的當前和未來需求。此外，該報告重點關注所有突出地區的個別應用部門的需求、估計和預測。

該研究報告還涵蓋了市場中主要參與者的全面概況和對全球競爭格局的深入看法。軟組織肉瘤診斷市場的主要參與者包括Adaptimmune, GE Healthcare, Siemens Healthcare, Shimadzu Corporation, Philips Healthcare, Hitachi Medical Corporation, Hologic, Esaote, Toshiba Medical System Corporation, Varian Medical Systems。這一部分包括對競爭格局的整體看法，其中包括各種戰略發展，如主要的合併和收購，未來的能力，夥伴關係，財務概況，合作，新產品的開發，新產品的推出，以及其他發展。

如果你有任何定製要求，請寫信給我們。我們的研究團隊可以根據您的需要提供定製報告。

區域前景銷售分析
簡介銷售分析
北美洲銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美地區國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概況、歷史和預測的銷售分析
- 歐洲分部銷售分析
- 歐洲國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概況、歷史和預測的銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太其他地區銷售分析
拉美地區銷售分析
- 概況、歷史和預測的銷售分析
- 拉美地區分部銷售分析
- 拉美地區國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉美其他地區銷售分析
中東和非洲銷售分析
- 概況、歷史和預測銷售分析
- 中東和非洲地區分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿聯酋銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第十章：軟組織肉瘤診斷公司的競爭格局

軟組織肉瘤診斷法市場競爭
夥伴關係/合作/協議
合併和收購
新產品發布
其他方面的發展

第十一章：公司簡介

前10名公司佔有率分析
市場集中度
Adaptimmune
- 公司概況
- 公司收入
- 產品
- 近期發展
GE Healthcare
- 公司概況
- 公司收入
- 產品
- 近期發展
Siemens Healthcare
- 公司概覽
- 公司收入
- 產品
- 近期發展
Shimadzu Corporation
- 公司概覽
- 公司收入
- 產品
- 近期發展
Philips Healthcare
- 公司概覽
- 公司收入
- 產品
- 近期發展
Hitachi Medical Corporation
- 公司概覽
- 公司收入
- 產品
- 近期發展
Hologic
- 公司概覽
- 公司收入
- 產品
- 近期發展
Esaote
- 公司概覽
- 公司收入
- 產品
- 近期發展
Toshiba Medical System Corporation
- 公司概覽
- 公司收入
- 產品
- 近期發展
Varian Medical Systems
- 公司概覽
- 公司收入
- 產品
- 近期發展情況

注意- 在公司簡介中，財務細節和最近的發展情況取決於可用性，可能不包括私人公司在內。

簡介目錄圖表

Product Code: VMR11219942

A soft tissue sarcoma is a form of cancer that affects the body's connective tissues, such as muscles, fat, blood vessels, and deep skin tissues. This sarcoma can occur anywhere in the body and is not easy to diagnose due to its diverse range of presentations and locations. Soft tissue sarcoma diagnostics typically begins with a thorough physical examination and a review of the patient's medical history. The healthcare provider may also order imaging tests, such as x-rays, MRI, or CT scans, to visualize the affected area and determine the size and location of the tumor. It is important to diagnose and treat soft tissue sarcoma as early as possible, as it can grow and spread quickly if left untreated.

Market Dynamics:

The development of new and improved diagnostic tests and technologies, such as advanced imaging techniques and biopsy methods, which can help identify the disease in its early stages, may contribute to the market's growth. Moreover, the growing awareness of the importance of early detection and treatment of cancer is scaling up regular check-ups and screenings; they may be more likely to seek out diagnostic tests, including those for soft tissue sarcoma, which may fuel the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of soft tissue sarcoma diagnostics. The growth and trends of soft tissue sarcoma diagnostics industry provide a holistic approach to this study.

Market Segmentation:

This section of the soft tissue sarcoma diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Angiosarcoma
Dermatofibrosarcoma Protuberans
Epithelioid Sarcoma
Gastrointestinal Stroma Tumor
Kaposi'S Sarcoma
Others

By Diagnostic Test

Diagnostic Imaging Test (X-Ray, Magnetic Resonance Imaging (Mri), Computed Tomography (Ct) Scan, Others)
Laboratory Tests
Others

By End-User

Hospitals
Specialty Clinics/Centers
Diagnostic Laboratories
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Soft Tissue Sarcoma Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the soft tissue sarcoma diagnostics market include Adaptimmune, GE Healthcare, Siemens Healthcare, Shimadzu Corporation, Philips Healthcare, Hitachi Medical Corporation, Hologic, Esaote, Toshiba Medical System Corporation, Varian Medical Systems. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . SOFT TISSUE SARCOMA DIAGNOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Diagnostic Test
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL SOFT TISSUE SARCOMA DIAGNOSTICS MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Angiosarcoma Historic and Forecast Sales by Regions
6.5 Dermatofibrosarcoma Protuberans Historic and Forecast Sales by Regions
6.6 Epithelioid Sarcoma Historic and Forecast Sales by Regions
6.7 Gastrointestinal Stroma Tumor Historic and Forecast Sales by Regions
6.8 Kaposi's Sarcoma Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL SOFT TISSUE SARCOMA DIAGNOSTICS MARKET ANALYSIS BY DIAGNOSTIC TEST

7.1 Overview by Diagnostic Test
7.2 Historical and Forecast Data
7.3 Analysis by Diagnostic Test
7.4 Diagnostic Imaging Test (X-ray, Magnetic resonance Imaging (MRI), Computed Tomography (CT) Scan, Others) Historic and Forecast Sales by Regions
7.5 Laboratory Tests Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL SOFT TISSUE SARCOMA DIAGNOSTICS MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Specialty Clinics/Centers Historic and Forecast Sales by Regions
8.6 Diagnostic Laboratories Historic and Forecast Sales by Regions
8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL SOFT TISSUE SARCOMA DIAGNOSTICS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE SOFT TISSUE SARCOMA DIAGNOSTICS COMPANIES

10.1. Soft Tissue Sarcoma Diagnostics Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF SOFT TISSUE SARCOMA DIAGNOSTICS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Adaptimmune
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. GE Healthcare
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Siemens Healthcare
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Shimadzu Corporation
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Philips Healthcare
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Hitachi Medical Corporation
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Hologic
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Esaote
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Toshiba Medical System Corporation
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Varian Medical Systems
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Type (USD MN)
Angiosarcoma Market Sales by Geography (USD MN)
Dermatofibrosarcoma Protuberans Market Sales by Geography (USD MN)
Epithelioid Sarcoma Market Sales by Geography (USD MN)
Gastrointestinal Stroma Tumor Market Sales by Geography (USD MN)
Kaposi's Sarcoma Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis Market by Diagnostic Test (USD MN)
Diagnostic Imaging Test (X-ray, Magnetic resonance Imaging (MRI), Computed Tomography (CT) Scan, Others) Market Sales by Geography (USD MN)
Laboratory Tests Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis by End-user (USD MN)
Hospitals Market Sales by Geography (USD MN)
Specialty Clinics/Centers Market Sales by Geography (USD MN)
Diagnostic Laboratories Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Soft Tissue Sarcoma Diagnostics Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Soft Tissue Sarcoma Diagnostics Report
Market Research Process
Market Research Methodology
Global Soft Tissue Sarcoma Diagnostics Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Type
Market Attractiveness Analysis by Diagnostic Test
Market Attractiveness Analysis by End-user
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Type (USD MN)
Angiosarcoma Market Sales by Geography (USD MN)
Dermatofibrosarcoma Protuberans Market Sales by Geography (USD MN)
Epithelioid Sarcoma Market Sales by Geography (USD MN)
Gastrointestinal Stroma Tumor Market Sales by Geography (USD MN)
Kaposi's Sarcoma Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by Diagnostic Test (USD MN)
Diagnostic Imaging Test (X-ray, Magnetic resonance Imaging (MRI), Computed Tomography (CT) Scan, Others) Market Sales by Geography (USD MN)
Laboratory Tests Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by End-user (USD MN)
Hospitals Market Sales by Geography (USD MN)
Specialty Clinics/Centers Market Sales by Geography (USD MN)
Diagnostic Laboratories Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Top Company Share Analysis